Verrica Pharmaceuticals Inc.
VRCANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for VRCA. That does not mean none is planned.
Get an email about VRCA's next catalysts
Track Verrica Pharmaceuticals (VRCA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
VRCA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.50 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
VP-315 3 Day Dosing/Week
Basal Cell Carcinoma
VP-315 2 Day Dosing/Week - Split Dose
Basal Cell Carcinoma
VP-315 3 Day Dosing/Week - Loading Dose
Basal Cell Carcinoma
VP-315 3 Day Dosing/Week - No Loading Dose
Basal Cell Carcinoma
VP-315 3 Day Dosing/Week - Split Dose
Basal Cell Carcinoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VP-315 3 Day Dosing/Week | Phase 2 | Basal Cell Carcinoma | - | - |
VP-315 2 Day Dosing/Week - Split Dose | Phase 2 | Basal Cell Carcinoma | - | - |
VP-315 3 Day Dosing/Week - Loading Dose | Phase 2 | Basal Cell Carcinoma | - | - |
VP-315 3 Day Dosing/Week - No Loading Dose | Phase 2 | Basal Cell Carcinoma | - | - |
VP-315 3 Day Dosing/Week - Split Dose | Phase 2 | Basal Cell Carcinoma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Verrica Pharmaceuticals Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Verrica Pharmaceuticals Inc.'s (VRCA) pipeline across Phase 2. Its lead program is VP-315 2 Day Dosing/Week - Split Dose (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Verrica Pharmaceuticals Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Verrica Pharmaceuticals Inc. (VRCA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track VRCA biotech catalysts?→
Add VRCA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Verrica Pharmaceuticals Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.